Boone Capital Management’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
Other funds holding IONS
Boone Capital Management's IONS Position: Q3 2026 in Review
Boone Capital Management sold out of Ionis Pharmaceuticals (IONS) in Q3 2026, closing a stake of 519,977 shares — an estimated $41.2M sold.
Boone Capital Management first reported a position in IONS in Q3 2025 and held it in 4 quarters. The position peaked at $41.2M in Q2 2026. 462 funds tracked by Wall St. Rank hold IONS as of Q3 2026.
- Boone Capital Management reported no remaining Ionis Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
- Boone Capital Management sold 519,977 Ionis Pharmaceuticals shares in Q3 2026, an estimated $41.2M.
- Boone Capital Management first reported a position in Ionis Pharmaceuticals in Q3 2025 and held it in 4 quarters.
- Boone Capital Management's Ionis Pharmaceuticals position peaked at $41.2M in Q2 2026.
- 462 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2026.
Based on Boone Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.